ACAD
39.27
+0.14
+0.36%
AEMD
7.64
-0.09
-1.16%
APRI
1.62
+0.01
+0.62%
ARNA
2.705
-0.045
-1.636%
ATEC
0.58
-0.01
-1.69%
CNAT
3.89
+0.04
+1.04%
CRXM
0.35
+0.01
+2.94%
CYTX
0.369
-0.001
-0.2973%
DXCM
87.78
-0.23
-0.26%
GNMK
9.51
0.00
0.00%
HALO
16.87
+0.02
+0.12%
ILMN
192.15
-3.3
-1.69%
INNV
0.101
0.00
0.00%
INO
7
-0.09
-1.27%
ISCO
3.32
-0.26
-7.26%
ISIS
51.73
+0.16
+0.31%
LGND
89.18
+0.24
+0.27%
LPTN
0.245
-0.005
-2.000%
MBVX
1.58
-0.07
-4.24%
MEIP
1.83
-0.08
-4.1832%
MNOV
3.04
-0.12
-3.80%
MRTX
25.4
-0.58
-2.23%
MSTX
0.459
-0.011
-2.340%
NBIX
48
-0.09
-0.19%
NUVA
50.99
-0.7
-1.35%
ONCS
5.75
-0.06
-1.03%
ONVO
2.51
+0.01
+0.40%
OREX
2.64
-0.11
-4.00%
OTIC
22.2
+0.64
+2.97%
QDEL
20.8
+0.04
+0.19%
RCPT
231.96
0.00
0.00%
RGLS
8.54
+0.09
+1.07%
RMD
51.11
-0.52
-1.01%
SCIE
0.014
0.00
0.00%
SPHS
0.828
-0.012
-1.429%
SRNE
12.75
+0.04
+0.31%
TROV
5.73
-0.21
-3.54%
VICL
0.601
-0.004
-0.7274%
VOLC
18
0.00
0.00%
ZGNX
19.35
-0.28
-1.43%
ACAD
39.27
+0.14
+0.36%
AEMD
7.64
-0.09
-1.16%
APRI
1.62
+0.01
+0.62%
ARNA
2.705
-0.045
-1.636%
ATEC
0.58
-0.01
-1.69%
CNAT
3.89
+0.04
+1.04%
CRXM
0.35
+0.01
+2.94%
CYTX
0.369
-0.001
-0.2973%
DXCM
87.78
-0.23
-0.26%
GNMK
9.51
0.00
0.00%
HALO
16.87
+0.02
+0.12%
ILMN
192.15
-3.3
-1.69%
INNV
0.101
0.00
0.00%
INO
7
-0.09
-1.27%
ISCO
3.32
-0.26
-7.26%
ISIS
51.73
+0.16
+0.31%
LGND
89.18
+0.24
+0.27%
LPTN
0.245
-0.005
-2.000%
MBVX
1.58
-0.07
-4.24%
MEIP
1.83
-0.08
-4.1832%
MNOV
3.04
-0.12
-3.80%
MRTX
25.4
-0.58
-2.23%
MSTX
0.459
-0.011
-2.340%
NBIX
48
-0.09
-0.19%
NUVA
50.99
-0.7
-1.35%
ONCS
5.75
-0.06
-1.03%
ONVO
2.51
+0.01
+0.40%
OREX
2.64
-0.11
-4.00%
OTIC
22.2
+0.64
+2.97%
QDEL
20.8
+0.04
+0.19%
RCPT
231.96
0.00
0.00%
RGLS
8.54
+0.09
+1.07%
RMD
51.11
-0.52
-1.01%
SCIE
0.014
0.00
0.00%
SPHS
0.828
-0.012
-1.429%
SRNE
12.75
+0.04
+0.31%
TROV
5.73
-0.21
-3.54%
VICL
0.601
-0.004
-0.7274%
VOLC
18
0.00
0.00%
ZGNX
19.35
-0.28
-1.43%
Home » Featured, SDBN Blog

Building & Leveraging Life Science Networks

Submitted by on February 24, 2012 – 5:52 pm

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.


five − = 0